Norman David Eansor, Director of Marker Therapeutics MRKR, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/11/17.

NE

NE

Norman David Eansor

Director

Company

Marker Therapeutics MRKR

First filing

23/06/08

Trades

8 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/11/17

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Marker TherapeuticsMRKR	Open-market buy	21/03/16	23/06/08	14,285 sh	$17.50	$249,987.5	+588.3%